Houston, TX, March 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced creating an innovative marketing strategy for its 15 newly-acquired intellectual properties.  A substantial portion of the properties focus on important unmet medical needs, both over the counter and pharmaceutical.

The 16th new product included in the newly developed marketing plan is FULL SALUTE(TM), a male ED (erectile dysfunction) product that contains E. brevicornum extract, an all-natural phosphorodiesterase-5 inhibitor (biosimilar to Cialas and Viagra).

AngioSoma President Alex Blankenship said, “We are excited about the prospects for our fully developed marketing plan that follows finalizing the settlement agreement to conclude the 2-year legal dispute between founder David Summers and AngioSoma.  We believe our plan will move the new products into the market.” 

ABOUT ANGIOSOMA, INC.

AngioSoma is a wellness company dedicated to bringing innovative, effective and high-quality supplement products to the medical, wellness and adult-use markets through our marketing subsidiary, SomaCeuticals™. 

Learn more at www.muscles4U.com and htttps://muscles4u.blogstop.com.  Stay up to date at Twitter: @tweetmuscles4u, Instagram and Facebook.

NOTICE REGARDING FORWARD LOOKING STATEMENTS

This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

CONTACT

AngioSoma, Inc.

Alex Blankenship

Alex@AngioSoma.com

(832) 781- 8521